lobbying_activities: 3089460

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts. Sortable columns (indexed): client_name, issue_code, filing_year, filing_uuid. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	is_no_activity	is_termination	received_date
3089460	2f0e61e5-8502-44aa-a5c8-fd110a3c0687	Q4	RED+BLUE STRATEGIES	400693064	PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)	2023	fourth_quarter	MMM	S. 2973 - Modernizing and Ensuring PBM Accountability Act - Issues related to the important role PBMs play in keeping drug prices low for public and private employers and their employees. HR 6363 - Further Continuing Appropriations and other Extenders Act - Support for critical government programs remaining operational and available. HR 5860 - Continuing Appropriations Act of FY 2024 and other Extensions Act - Support for critical government programs remaining operational and available. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to pharmacy benefit managers and their role in keeping drug prices lower for patients. H.R. 3561 - The PATIENT Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. S. 1967 - The PBM Act - Issues related to delinking and limiting current tools used by PBMS to manage pharmacy benefits in Medicare Issues related to prescription drug supply chain integrity and transparency. Issues related to the implementation of the Inflation Reduction Act for purposes of ensuring access to affordable medications for Medicare beneficiaries and people across the United States.	HOUSE OF REPRESENTATIVES,SENATE	0	0	2023-12-31T12:03:25-05:00